Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison T Stopeck

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Physics in Medicine and Biology|June 21, 2012
Task-based evaluation of segmentation algorithms for diffusion-weighted MRI without using a gold standardAbhinav K Jha, Matthew A Kupinski, Jeffrey J Rodríguez, et al.
Proceedings of Spie--The International Society for Optical Engineering|December 15, 2010
Evaluating segmentation algorithms for diffusion-weighted MR images: a task-based approachAbhinav K Jha, Matthew A Kupinski, Jeffrey J Rodríguez, et al.
Disease Markers|March 5, 2016
Circulating Carbonic Anhydrase IX and Antiangiogenic Therapy in Breast CancerUrsa Brown-Glaberman, Marilyn Marron, Pavani Chalasani, et al.
Nutrition and Cancer|November 9, 2010
Changes in body weight and metabolic indexes in overweight breast cancer survivors enrolled in a randomized trial of low-fat vs. reduced carbohydrate dietsCynthia A Thomson, Alison T Stopeck, Jennifer W Bea, et al.
Cancer|October 22, 2008
A phase 1 trial of 2 dose schedules of ABT-510, an antiangiogenic, thrombospondin-1-mimetic peptide, in patients with advanced cancerMichael S Gordon, David Mendelson, Robert Carr, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2002
Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the breastJulia A Coronella, Catherine Spier, Matthew Welch, et al.
Cancer Medicine|April 1, 2015
A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancerPavani Chalasani, Marilyn Marron, Denise Roe, et al.
Journal of Bone Oncology|April 5, 2022
Risk factors associated with skeletal-related events following discontinuation of denosumab treatment among patients with bone metastases from solid tumors: A real-world machine learning approachDionna Jacobson, Benoit Cadieux, Celestia S Higano, et al.
Leukemia & Lymphoma|August 19, 2014
Assessment of carbonic anhydrase IX expression and extracellular pH in B-cell lymphoma cell line modelsLiu Qi Chen, Christine M Howison, Catherine Spier, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 7, 2010
Sulindac and sulindac metabolites in nipple aspirate fluid and effect on drug targets in a phase I trialPatricia A Thompson, Chiu-Hsieh Hsu, Sylvan Green, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Physics in Medicine and Biology|June 21, 2012
Task-based evaluation of segmentation algorithms for diffusion-weighted MRI without using a gold standardAbhinav K Jha, Matthew A Kupinski, Jeffrey J Rodríguez, et al.
Proceedings of Spie--The International Society for Optical Engineering|December 15, 2010
Evaluating segmentation algorithms for diffusion-weighted MR images: a task-based approachAbhinav K Jha, Matthew A Kupinski, Jeffrey J Rodríguez, et al.
Disease Markers|March 5, 2016
Circulating Carbonic Anhydrase IX and Antiangiogenic Therapy in Breast CancerUrsa Brown-Glaberman, Marilyn Marron, Pavani Chalasani, et al.
Nutrition and Cancer|November 9, 2010
Changes in body weight and metabolic indexes in overweight breast cancer survivors enrolled in a randomized trial of low-fat vs. reduced carbohydrate dietsCynthia A Thomson, Alison T Stopeck, Jennifer W Bea, et al.
Cancer|October 22, 2008
A phase 1 trial of 2 dose schedules of ABT-510, an antiangiogenic, thrombospondin-1-mimetic peptide, in patients with advanced cancerMichael S Gordon, David Mendelson, Robert Carr, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2002
Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the breastJulia A Coronella, Catherine Spier, Matthew Welch, et al.
Cancer Medicine|April 1, 2015
A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancerPavani Chalasani, Marilyn Marron, Denise Roe, et al.
Journal of Bone Oncology|April 5, 2022
Risk factors associated with skeletal-related events following discontinuation of denosumab treatment among patients with bone metastases from solid tumors: A real-world machine learning approachDionna Jacobson, Benoit Cadieux, Celestia S Higano, et al.
Leukemia & Lymphoma|August 19, 2014
Assessment of carbonic anhydrase IX expression and extracellular pH in B-cell lymphoma cell line modelsLiu Qi Chen, Christine M Howison, Catherine Spier, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 7, 2010
Sulindac and sulindac metabolites in nipple aspirate fluid and effect on drug targets in a phase I trialPatricia A Thompson, Chiu-Hsieh Hsu, Sylvan Green, et al.
Pageof 5